John H. Streiff

DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.

DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.

DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.

DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.

DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.